In Global News: Ectopia Cordis, LOTUS Valve Delays, and Medical Device Cybersecurity

Patient Care

A baby in the UK has surgery to put her ectopic heart back inside her chest.

The first open-heart surgery at a district-level hospital is performed in Vietnam, as surgeons at the Thủ Đức District Hospital in Ho Chi Minh City closed an atrial septal defect in a young man.

Nestle Health Sciences is launching a patient education website to promote awareness of its nutritional drink designed for patients undergoing major elective surgery.

Three people received new organs when surgeons at the Cleveland Clinic in Abu Dhabi, UAE, performed the country’s first cadaver heart and kidney transplant.

Drugs and Devices

The American Hospital Association wants increased oversight on the cybersecurity of medical devices.

Boston Scientific has delayed the reintroduction of its voluntarily-recalled LOTUS Edge Aortic Valve, which had been expected in early 2018. They will provide more information on the valve’s status in February 2018.

Research, Trials, and Funding

Research published in JAMA Psychiatry investigated the association between congenital cardiac malformations and use of attention-deficit/hyperactivity disorder drugs during pregnancy.

The REMOVE Trial will test CytoSorb, an extracorporeal blood purification therapy, for preventing vasodilatory shock in patients with infective endocarditis; the trial will be funded by the German Federal Ministry of Education and Research.

Researchers at Washington University School of Medicine in St Louis, Missouri, have used entirely noninvasive cardiac radiation to treat five patients with ventricular tachycardia.